Table 3.

Multivariate logistic regression analysis of independent risk factors for IP

Factors	B	SE	Wald	P	OR	95% CI
LDH (Increase)	0.856	0.459	7.574	0.001	3.114	1.428-7.595
LDH (Non-increase)	1.339	0.451	6.055	0.527	3.672	1.985-6.447
β2-MG (Increase/Non-increase)	0.682	0.249	4.528	0.133	4.550	2.334-7.958
ESR (Increase)	1.975	0.551	4.907	0.004	5.587	2.218-13.672
ESR (Non-increase)	0.779	0.593	3.669	0.598	2.330	1.409-5.677
Plasma albumin (Decrease/Non-decrease)	0.998	0.698	3.556	0.087	1.378	0.698-4.330
leukocyte count (Increase/Non-increase)	0.807	0.446	5.609	0.078	2.356	1.509-5.669
Absolute value of lymphocytes (Increase/Non-increase)	1.335	0.871	3.495	1.044	3.409	2.330-6.409
Medullary inhibition (I-II degree/III-IV degree)	0.648	0.450	4.597	0.948	4.559	1.449-5.499
Liposome doxorubicin	1.533	0.550	7.662	0.000	3.960	1.104-5.419
Hemoglobin (Diminished/Undiminished)	0.556	0.456	5.697	0.459	2.449	1.009-5.650
RTX	1.841	0.7883	4.558	0.032	2.558	1.456-10.664

Note: B: regression coefficient; SE: standard error; OR: odds ratio; 95% CI: 95% confidence interval.